Connection

Laure Gossec to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Laure Gossec has written about Antibodies, Monoclonal, Humanized.
Laure Gossec
Connection Strength
0.252
Antibodies, Monoclonal, Humanized
  1. Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale. J Rheumatol. 2019 10; 46(10):1259-1267.
    View in: PubMed
    Score: 0.164
  2. Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. Arthritis Res Ther. 2018 06 19; 20(1):129.
    View in: PubMed
    Score: 0.039
  3. Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature. J Rheumatol. 2018 01; 45(1):6-13.
    View in: PubMed
    Score: 0.037
  4. Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients. J Rheumatol. 2020 06 01; 47(6):854-864.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.